Morgan Stanley misses €500m Probitas IPO

Morgan Stanley is missing from the latest line-up of banks appointed to lead the €500m ($592m) initial public offering for Probitas Pharma, the Spanish bio-pharmaceutical group. It had been one of four banks selected to float the company three years ago.

Banco Bilbao Vizcaya Argentaria, Deutsche Bank and Santander Central Hispano - have all been reappointed.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump